BioSymetrics (a Lunai Bioworks company)

BioSymetrics is a leading biotechnology company focused on revolutionizing drug discovery through advanced phenomics-driven approaches. Located in Boston, MA, at the primary address of Boston, MA 02118, US, BioSymetrics integrates clinical and experimental data with cutting-edge machine learning techniques to translate human disease biology and accelerate the development of precision medicines. With additional locations at 65 Broadway, Suite 1105, New York, NY 10003, US, and 180 John Street, 7th floor, Toronto, Ontario, CA, BioSymetrics partners with prominent healthcare and life science organizations, enhancing their understanding of diseases and expediting the discovery of effective drugs.

BioSymetrics leverages its patent-pending Contingent-AI™ technology to detect and correct biases during machine learning pre-processing, identifying crucial feature sets for analysis. This innovative technology, combined with a unique in silico and in vivo experimental practice, allows BioSymetrics to generate faster and more precise predictive results for drug discovery research. Committed to innovation and excellence, BioSymetrics is dedicated to transforming the future of medicine.

BioSymetrics is poised for continued growth and success in the biotechnology industry. The team at BioSymetrics is currently expanding, and the company is eager to welcome talented individuals to contribute to its mission. BioSymetrics is actively enhancing its company showcase and product listings. We invite the company’s management to create a customized and exclusive company showcase and product listing on our platform.